Skip to main content

RUSH ENTERPRISES INC \TX\

For the period ended May 19, 2026. Filed Apr 7, 2026.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

May 19, 2026 · Filed Apr 7, 2026

RUSHB$58.61-0.8%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

2025 Potential Payments Upon Termination

2025 Potential Payments Upon Termination****(1)**

Name · Benefit · Involuntary Termination Absent a Change in Control ($) · Involuntary Termination Upon a Change in Control ($) · Death/ Disability ($)
W.M. “Rusty” RushCash payments7,248,515(3)7,248,515(3)−
Acceleration of equity awards−10,867,21010,867,210(4)
Continuation of life and health insurance87,931(5)87,931(5)
280G Gross-Up (2) · − · − · −
Total7,336,44618,203,65610,867,210
Steven L. KellerCash payments871,318(6)2,528,636(7)−
Acceleration of equity awards−3,657,777(4)3,657,777(4)
Continuation of life and health insurance25,793(8)51,586(9)−
280G Gross-Up (2) · − · − · −
Total897,1116,237,9993,657,777
Jason Wilder(10)Cash payments837,868(6)2,413,736(7)−
Acceleration of equity awards−2,666,105(4)2,666,105(4)
Continuation of life and health insurance30,509(8)61,018(9)−
280G Gross-Up (2) · − · − · −
Total868,3775,140,8592,666,105
Jody PollardCash payments779,463(6)2,310,634(7)−
Acceleration of equity awards−2,777,097(4)2,777,097(4)
Continuation of life and health insurance31,818(8)63,635(9)−
280G Gross-Up (2) · − · - · −
Total811,2815,151,3662,777,097
Corey LoweCash payments822,324(6)2,150,134(7)−
Acceleration of equity awards−2,666,105(4)2,666,105(4)
Continuation of life and health insurance14,104(8)28,209(9)−
280G Gross-Up (2) · − · − · −
Total836,4284,844,4482,666,105
(1)Amounts reflected in the table were calculated assuming a December 31, 2025, termination date, which was the last business day of the 2025 fiscal year. Each of the named executive officers listed in the above table is entitled to receive amounts earned during the term of his employment regardless of the manner in which he is terminated, including termination for Cause. These amounts include base salary, unused vacation pay and other benefits such named executive officer may be entitled to receive under applicable employee benefit plans and are not reflected in the table. The table reflects only the additional compensation and benefits (collectively, “Additional Compensation”) the listed named executive officers are estimated to receive upon termination. The listed named executive officers are not entitled to any Additional Compensation in the event they are terminated for Cause. The actual amounts to be paid to an officer can only be determined at the time of his actual termination.

The term “Involuntary Termination” has the same meaning in this table as it does in the Transition Plan, which is set forth above.

(2)The Section 280G excise tax gross-up payment on an actual termination may differ based on factors such as timing of employment termination and payments, methodology for valuing stock options, future stock option exercises, changes in compensation, and reasonable compensation analyses the Company is required to make. In 2011, the Compensation and Human Capital Committee adopted a policy prohibiting the Company from entering into any future change in control arrangements with executive officers that provide for excise tax gross-up payments, unless such arrangement is approved by shareholders. Pursuant to the policy, any participant who entered the Transition Plan after March 3, 2011, is not entitled to any excise tax gross-up payments. Consequently, Jody Pollard and Corey Lowe are not entitled to any Section 280G excise tax gross-up payment.
(3)The amount reflects the sum of (a) two times the respective named executive officer’s current rate of base salary, plus (b) the average annual cash bonus received in the three previous calendar years.
(4)The amount reflects the value of accelerating the respective officer’s unvested equity awards upon termination, death or disability. This value is based upon the closing sale price of the Company’s Class A Common Stock and Class B Common Stock, as quoted on the NASDAQ® Global Select Market on December 31, 2025, of $53.94 and $56.26, respectively.
(5)The amount reflects the Company’s estimated cost to continue life and health insurance benefits up to 48 months. These estimated costs were based upon the Company’s actual costs in providing the benefits in 2025.
(6)The amount reflects the sum of (a) the respective named executive officer’s current rate of base salary, plus (b) one-half times his annual cash bonus received for the 2025 calendar year.
(7)The amount reflects the sum of (a) two times the respective named executive officer’s current rate of base salary, plus (b) two times his highest annual cash bonus received in any of the previous five years.
(8)The amount reflects the Company’s estimated cost to continue life and health insurance benefits for up to 12 months. These estimated costs were based upon the Company’s actual costs in providing the benefits in 2025.
(9)The amount reflects the Company’s estimated cost to continue life and health insurance benefits up to 24 months. These estimated costs were based upon the Company’s actual costs in providing the benefits in 2025.
(10)In connection with Mr. Wilder’s resignation from his position of Chief Operating Officer, he stopped participating in the Transition Plan effective March 18, 2026.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.